Biostax Corp (BTAX)

[noreen]

This stock would move with the announcement of an investor conference call to address numerous outstanding issues.

This stock has been heavily demoted, and there is plenty of evidence that I've mentioned in the past as to why I believe this. I'm happy to link you to what I'm talking about if you are unfamiliar with what I'm talking about??? Just let me know if you have no idea what I'm talking about.

With that being said, the company does not care to address issues with shareholders. They don't promote. They demote. Why update shareholders and relieve concerns? In my opinion, they're happy keeping the price low until sales arrive, because they must be confident that sales will eventually arrive.

Also, not updating shareholders is very typical with most penny stocks.

It appears the market doesn't believe any of the hype to date.

If your evidence of this is solely based on the stock price, I would say that that is not at all supporting evidence. The PPS is a result of a noteholder holding the stock down, and more specifically, the PPS they bring it down to is a function of the remaining debt to the noteholder. As the debt decreases, the noteholder has to bring the PPS down even further to be guaranteed the full equity they are allowed to have. We had Phoenix Fund Management working their magic for a while, and now according to the most recent 8-k on Nov 2nd, we have Iliad Research and Trading. When a note is present in which a noteholder gets the benefit of converting according to "the lowest trading price of the last [x] trading days", then the noteholder has every reason to hold the stock down (until they are ready to convert their entire remaining debt to equity).This is true in other penny stocks as well. Check out OWCP for a good example, and look at the q-10 for Q2 2016 to see the specific note related to holding down OWCP before it exploded in late 2016 when revenues finally began - the stock went from about .30 maybe 5 years ago, to a low of .0036 in 2016, to over $3.00 per share that first quarter they had revenue, and the first quarter of revenue was only $50k. They subsequently had two quarters after that (Q1 and Q2 of this year) with no revenue, and the stock has come back down to the .30's. Check out the message board for OWCP according to the dates when the stock started going up in 2016. The people buying the stock knew exactly where the stock was headed, and they also knew that the PPS was low strictly because of the noteholder.

Re: Nigeria:

I have no idea what is going on here, and wish I knew. However, the following is a quote from the 9/6 PR and 9/8 8-k...

" The revenues generated from our successful launch of Lodonal in Kenya should enable us to achieve profitability by the middle of 2018 and significantly strengthens our position to expand across additional countries, such as Nigeria, which is expected to be announced by the fourth quarter of this year,” concluded Ms. Griffin."

This has been pushed back multiple times, yes. But she did say "by the 4th quarter" here - whatever that means - I don't know.

Re: Kenya/Omaera:..... "Upon termination of the Agreement for any reason"....

Everything you mentioned here, again, starts with "Upon termination of the Agreement"...

Nowhere does it say that Omaera is ALLOWED to terminate the agreement WITHOUT PERMISSION OF IMUN. I would expect (but this is just my interpretation) that Omaera can't just terminate the contract without IMUN's permission, otherwise what's the point of the contract in the first place??? The contract says that if Omaera doesn't give a purchase order according to the timeline at 6 months, 1 year, 2 years, 3 years, etc, then they are STILL REQUIRED to pay the profits to IMUN that IMUN would have received from those guaranteed minimums at each place in the timeline. So it really wouldn't make sense that Omaera has the right to terminate the agreement without permission of IMUN. Otherwise, as you also said, it's a pointless contract. So I believe that when the contract says "Upon termination...", it means if Omaera and IMUN both mutually agreed to terminate the contract. Again, just my interpretation here.

Additionally, I have not found job postings anywhere for the Sales staff Omaera

Maybe they don't need to hire anyone. They already sell other drugs. I'm not convinced they need NEW sales reps. Again, just my interpretation.

I could not find Lodonal or LDN on Omaera's website.

They haven't given us a purchase order yet, so they shouldn't have any Lodonal to sell their customers yet. So it should not be on their website to sell yet IMO. Again, just my interpretation.

I could not Add to Cart any of the items listed on Omaera's site.

I would imagine that any products for sale would require a prescription, therefore would not just be for sale to anybody browsing the internet. Just my interpretation, again, but it's the same in United States (I believe) - you can't just buy Low dose naltrexone on the Internet without a prescription from a doctor. Try and go to Skip's Pharmacy and buy Low dose naltrexone online.

https://www.skipspharmacy.com/wplog/

From that link, it looks like the only product that can be "added to your cart" is the High dose Biotin, which I'm assuming requires no prescription. All the other drugs, including LDN (or at least the ones I saw when I looked at it very quickly) only say "Learn more", and don't allow you to add it to your cart. You can't add low dose naltrexone to your cart on Skip's Pharmacy site.